Stephanie Davis
Stock Analyst at Barclays
(0.82)
Main Sectors:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
DGX Quest Diagnostics | Maintains: Equal-Weight | 175 185 | 176.92 | 4.57% | 5 | Apr 23, 2025 | |
WAY Waystar Holding | Maintains: Overweight | 50 45 | 39.34 | 14.39% | 6 | Apr 14, 2025 | |
OPRX OptimizeRx | Maintains: Equal-Weight | 11 5 | 13.43 | -62.77% | 3 | Nov 14, 2024 | |
DOCS Doximity | Maintains: Overweight | 52 75 | 61.69 | 21.58% | 5 | Nov 11, 2024 | |
LFST LifeStance Health Gr | Maintains: Underweight | 6 7 | 4.79 | 46.14% | 2 | Nov 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 10 6 | 4.71 | 27.39% | 7 | Nov 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 39 19 | 11.79 | 61.15% | 1 | Nov 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 263 290 | 296.23 | -2.1% | 2 | Nov 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 20 24 | 22.01 | 9.04% | 3 | Nov 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 117 133 | 164.93 | -19.36% | 2 | Nov 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 39 58 | 29.84 | 94.37% | 2 | Oct 31, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 2 3 | 2.77 | 8.3% | 7 | Oct 29, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 1 1 | n/a | n/a | 3 | Oct 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 6 5 | 7.02 | -28.77% | 10 | Oct 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 213 249 | 261.89 | -4.92% | 3 | Aug 2, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 14 14 | n/a | n/a | 6 | Feb 28, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 12 10 | 9.19 | 8.81% | 6 | Jan 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 29 | 28.99 | 0.03% | 11 | Jan 3, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Equal-Weight | 11 | n/a | n/a | 10 | Jan 3, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 34 | 8.29 | 310.13% | 9 | Feb 23, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 59 34 | 21.46 | 58.43% | 3 | Jan 5, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 242 233 | 284.29 | -18.04% | 9 | Dec 2, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 20 17 | 4.06 | 318.72% | 10 | Nov 9, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 24 25 | 23.94 | 4.43% | 6 | Oct 26, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 67 76 | 102.16 | -25.61% | 5 | Jun 7, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 11 4 | 10.5 | -61.9% | 7 | May 9, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 88 95 | 94.92 | 0.08% | 4 | Dec 21, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 34 36 | 79.13 | -54.51% | 4 | Oct 29, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 45 41 | 32.25 | 27.13% | 4 | Aug 19, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 60 56 | 55.99 | 0.02% | 7 | May 11, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 55 53 | 16.47 | 221.8% | 2 | Feb 26, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 31 35 | n/a | n/a | 2 | Aug 10, 2020 |